Build Buy Modify
AI is changing the economics of software. David Dambman revisits the build, modify, buy decision for lab automation and explains why risk and business criticality now drive the choice.
AI is changing the economics of software. David Dambman revisits the build, modify, buy decision for lab automation and explains why risk and business criticality now drive the choice.
No matter how many instruments you add to an arm-based system, the throughput ceiling stays. One arm. One plate. One sequence. The arm is always the constraint. Here is what…
The mobile robot sitting in the corner of a lab is not a myth. It is one of the most consistent things we hear from the lab automation community. A…
As a community, we usually talk about innovation in terms of technology. However, behind every technology breakthrough is a company made of people, processes, and capabilities that drives it forward….
For decades, the laboratory automation landscape has been predominantly shaped by powerful, yet stationary, robotic arms. These systems, often bolted to a bench, are synonymous with precision and efficiency within…
Artificial Intelligence (AI) is no longer a futuristic fantasy; it’s rapidly becoming a transformative force in life science R&D. From accelerating drug discovery to optimizing experimental design and uncovering novel…
The life sciences landscape is a whirlwind of innovation. Breakthroughs in genomics, personalized medicine, and novel therapeutics are happening at an unprecedented pace. But for many growing biotech and pharmaceutical…